Ignite Creation Date:
2024-05-06 @ 1:20 AM
Last Modification Date:
2024-10-26 @ 11:02 AM
Study NCT ID:
NCT01785810
Status:
COMPLETED
Last Update Posted:
2021-01-11
First Post:
2013-02-05
Brief Title:
Phase II Maraviroc for GVHD Prevention
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Abramson Cancer Center at Penn Medicine
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02
Start Date Type:
ACTUAL
Primary Completion Date:
2016-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-05
First Submit QC Date:
February 6 2013
Study First Post Date:
2013-02-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-01-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2020-04-16
Disp First Submit QC Date:
April 16 2020
Disp First Post Date:
2020-04-22
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-12-16
Last Update Post Date:
2021-01-11
Last Update Post Date Type:
ACTUAL